Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating […]
Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana
Zipline, the global leader in instant logistics, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced […]
MyLife Technologies Raises US$4.0 Million to Further Develop its Vaccine Delivery Technology Through Painless Ceramic Vaccine Patches for 'Pandemic Preparedness'
MyLife Technologies, a Dutch vaccine and drug delivery company, focusing on the development of ceramic […]
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has announced the establishment of […]
Caris’ Precision Oncology Alliance Welcomes The Georgia Cancer Center at Augusta University
Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]
Compugen Announces Collaboration Expansion with Bristol Myers Squibb Alongside $20 Million Equity Investment
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today […]
MoveAI™ Technology by WizeCare Shapes the Future of Physical Rehabilitation
WizeCare, a health technology company leading the way in the delivery of intelligent, accessible, and exciting […]
Generate Life Sciences to be Acquired by CooperCompanies
Generate Life Sciences® announces it has entered into an agreement to be acquired by the publicly […]
Whole Genome Sequencing Improves Diagnosis of Rare Diseases and Shortens Diagnostic Journeys for Patients, According to World First Study
A world-first scientific study, published today in the New England Journal of Medicine, has shown that […]
CrestOptics Acquired by Apposite Capital LLP to Enable Rapid Commercial Growth and Innovation in Bioimaging
CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more